Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Jie-Ling Miao · SciRah

Researcher profile · Semantic Scholar

Jie-Ling Miao

Share profile

Jie-Ling Miao — researcher profile on SciRah

h-index: 14
Works: 34
Citations: 800

Most-cited papers

Brief Report: SWOG S1400D (), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)
C. Aggarwal, M. Redman, P. Lara, H. Borghaei +11 more
2019Journal of Thoracic Oncology88 citations Open access
Semantic Scholar
On the design, conduct and lessons learned from Lung-MAP (SWOG S1400): A biomarker-driven master protocol to evaluate biomarker-driven therapies for previously-treated squamous lung cancer
M. Redman, V. Papadimitrakopoulou, K. Minichiello, F. Hirsch +22 more
2020The Lancet Oncology83 citations Open access
Semantic Scholar
Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307.
J. Gralow, W. Barlow, A. Paterson, Jie-Ling Miao +19 more
2019Journal of the National Cancer Institute72 citations Open access
Semantic Scholar
Brief Report: SWOG S1400B (), A Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)
C. Langer, M. Redman, J. Wade, C. Aggarwal +10 more
2019Journal of Thoracic Oncology67 citations Open access
Semantic Scholar
SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-study)
M. Edelman, M. Redman, K. Albain, E. McGary +9 more
2019Journal of Thoracic Oncology67 citations Open access
Semantic Scholar
Circulating Tumor Cell Clusters in patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study
C. Paoletti, Jie-Ling Miao, E. Dolce, E. Darga +7 more
2019Clinical Cancer Research57 citations Open access
Semantic Scholar
Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403.
S. Goldberg, M. Redman, R. Lilenbaum, K. Politi +12 more
2020Journal of Clinical Oncology49 citations Open access
Semantic Scholar
Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).
A. Tsao, Jie-Ling Miao, I. Wistuba, N. Vogelzang +10 more
2019Journal of Clinical Oncology44 citations Open access
Semantic Scholar
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)
N. Leighl, M. Redman, N. Rizvi, F. Hirsch +15 more
2021Journal for ImmunoTherapy of Cancer42 citations Open access
Semantic Scholar
Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416).
Priyanka Sharma, E. Rodler, W. Barlow, J. Gralow +16 more
202041 citations
Semantic Scholar
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
D. Kizub, Jie-Ling Miao, M. Schubert, A. Paterson +7 more
2020Supportive Care in Cancer35 citations Open access
Semantic Scholar
A Phase II Study of Talazoparib in Patients with Homologous Recombination Repair Deficient Squamous Cell Lung Cancer (Lung-MAP Sub-Study S1400G)
T. Owonikoko, M. Redman, L. Byers, F. Hirsch +13 more
2021Clinical Lung Cancer23 citations Open access
Semantic Scholar
A dose-finding study followed by a phase II randomized, placebo-controlled trial of chemoradiotherapy with or without veliparib in stage III non-small cell lung cancer: SWOG 1206 (8811)
A. Argiris, Jie-Ling Miao, M. Cristea, Allen M. Chen +14 more
2021Clinical Lung Cancer23 citations Open access
Semantic Scholar
Phase II study of the FGFR inhibitor AZD4547 in previously treated patients with FGF pathway-activated stage IV squamous cell lung cancer (SqNSCLC): LUNG-MAP sub-study SWOG S1400D.
C. Aggarwal, M. Redman, P. Lara, H. Borghaei +9 more
201715 citations
Semantic Scholar
A phase II study of GDC-0032 (taselisib) for previously treated PI3K positive patients with stage IV squamous cell lung cancer (SqNSCLC): LUNG-MAP sub-study SWOG S1400B.
J. Wade, C. Langer, M. Redman, C. Aggarwal +8 more
201714 citations
Semantic Scholar
S1507: Phase II study of docetaxel and trametinib in patients with G12C or non-G12C KRAS mutation positive (+) recurrent non-small cell lung cancer (NSCLC).
S. Gadgeel, Jie-Ling Miao, J. Riess, P. Mack +8 more
2019Journal of Clinical Oncology11 citations
Semantic Scholar
A phase II study of palbociclib (P) for previously treated cell cycle gene alteration positive patients (pts) with stage IV squamous cell lung cancer (SCC): Lung-MAP sub-study SWOG S1400C.
M. Edelman, M. Redman, K. Albain, E. McGary +9 more
201711 citations
Semantic Scholar
Paired Phase II Studies of Erlotinib/Bevacizumab in Advanced Bronchioloalveolar Carcinoma or in Never-Smokers with Advanced Non-Small-Cell Lung Cancer (NSCLC): SWOG S0635 and S0636 Trials
H. West, J. Moon, A. Wozniak, P. Mack +9 more
2017Clinical Lung Cancer9 citations Open access
Semantic Scholar
A phase II study of talazoparib (BMN 673) in patients with homologous recombination repair deficiency (HRRD) positive stage IV squamous cell lung cancer (Lung-MAP Sub-Study, S1400G).
T. Owonikoko, M. Redman, L. Byers, F. Hirsch +13 more
2019Journal of Clinical Oncology8 citations
Semantic Scholar
SWOG S0905: A randomized phase II study of cediranib versus placebo in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma.
A. Tsao, Jie-Ling Miao, I. Wistuba, N. Vogelzang +10 more
20188 citations
Semantic Scholar
OA10.04 Afatinib With or Without Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Safety and Efficacy Results from SWOG S1403
S. Goldberg, M. Redman, R. Lilenbaum, K. Politi +10 more
2018Journal of Thoracic Oncology8 citations Open access
Semantic Scholar
Estimating Global Treatment Toxicity Burden from Adverse Events Data
Shing M. Lee, D. Hershman, Jie-Ling Miao, X. Zhong +2 more
2017Cancer8 citations Open access
Semantic Scholar
OA 14.07 Progress in Lung Squamous Cell Carcinoma from the Lung-MAP Master Protocol (S1400) Sub-Studies S1400A, S1400B, S1400C and S1400D
R. Herbst, M. Redman, D. Gandara, F. Hirsch +33 more
20175 citations Open access
Semantic Scholar
SWOG S1206: A dose-finding study of veliparib (ABT-888) added to chemoradiotherapy (CRT) with carboplatin (C) and paclitaxel (P) for unresectable stage III non-small cell lung cancer (NSCLC).
M. Cristea, Jie-Ling Miao, A. Argiris, Allen M. Chen +8 more
20164 citations
Semantic Scholar
S1206: A dose-finding study followed by a phase II randomized placebo-controlled trial of chemoradiotherapy (CRT) with or without veliparib in stage III non-small cell lung cancer (NSCLC).
A. Argiris, Jie-Ling Miao, M. Cristea, Allen M. Chen +14 more
2019Journal of Clinical Oncology3 citations
Semantic Scholar
A comparison of nurses’ and physicians’ perception of cancer treatment burden based on reported adverse events
Shing M. Lee, Jie-Ling Miao, Ruby Wu, J. Unger +2 more
2019Health and Quality of Life Outcomes3 citations Open access
Semantic Scholar
Factors associated with osteonecrosis of the jaw in women with breast cancer receiving high-dose bisphosphonates to prevent breast cancer metastases as part of the SWOG 0307 trial.
D. Kizub, Jie-Ling Miao, M. Schubert, A. Paterson +7 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
P3.02b-052 Afatinib with or without Cetuximab for First-Line Treatment of EGFR-Mutant NSCLC: Interim Safety Results of SWOG S1403: Topic: EGFR Clinical
S. Goldberg, J. Moon, R. Lilenbaum, K. Politi +8 more
20171 citations Open access
Semantic Scholar
Brief Report: SWOG S1400D (), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)
Charu Aggarwal, M. Redman, Primo N. Lara, Hossein Borghaei +14 more
20200 citations
Semantic Scholar
Abstract P2-18-02: Fractures in women with breast cancer receiving high-dose bisphosphonates to prevent breast cancer metastases as part of the SWOG S0307 trial (ClinicalTrials.gov Identifier: NCT00127205)
Rachel L. Yung, Jie-Ling Miao, A. Paterson, M. Clemons +6 more
20200 citations
Semantic Scholar
SWOG S1400F (NCT03373760): A phase II study of durvalumab plus tremelimumab for previously treated patients with acquired resistance to PD-1 checkpoint inhibitor therapy and stage IV squamous cell lung cancer (Lung-MAP Sub-study).
N. Leighl, M. Redman, N. Rizvi, Fred R. Hirsch +15 more
20200 citations
Semantic Scholar
Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy±everolimusin patients with high-risk, hormone receptor (HR) positive, HER2-negative breast cancer (BC): SWOG/NRG/Alliance S1207 (NCT01674140)
M. Chávez-MacGregor, W. Barlow, L. Pusztai, P. Rastogi +6 more
2019Breast0 citations
Semantic Scholar
MA11.06 SWOG 0124: Platinum-Sensitivity Status and Post-Progression Survival in Patients with Extensive-Stage Small Cell Lung Cancer
P. Lara, Jie-Ling Miao, J. Moon, M. Redman +2 more
20170 citations Open access
Semantic Scholar
P3.01-046 Longitudinal Analysis of Plasma CtDNA in EGFR-Mutant NSCLC: SWOG S1403 Trial of Afatinib with or Without Cetuximab
P. Mack, Jie-Ling Miao, K. Banks, Rebekah A. Burich +11 more
20170 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Kelly×24
Invite
K. Kelly — researcher profile on SciRah
D. Gandara×24
Invite
D. Gandara — researcher profile on SciRah
M. Redman×23
Invite
M. Redman — researcher profile on SciRah
V. Papadimitrakopoulou×13
Invite
V. Papadimitrakopoulou — researcher profile on SciRah

×13

Invite

R. Herbst — researcher profile on SciRah

Invite

P. Mack — researcher profile on SciRah

Invite

J. Bradley — researcher profile on SciRah

Invite

J. Moon — researcher profile on SciRah

Invite

J. Gralow — researcher profile on SciRah

Invite

W. Barlow — researcher profile on SciRah

G. Hortobagyi×7

Invite

G. Hortobagyi — researcher profile on SciRah

T. Stinchcombe×7

Invite

T. Stinchcombe — researcher profile on SciRah